Sunshine Biopharma, Inc·4

Mar 5, 4:05 PM ET

Slilaty Steve N. 4

4 · Sunshine Biopharma, Inc · Filed Mar 5, 2024

Insider Transaction Report

Form 4
Period: 2024-03-04
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
  • Purchase

    Series B Preferred Stock

    2024-03-04$0.10/sh+100,000$10,000130,000 total

Documents

1 file
  • 4
    ownership.xmlPrimary